EMA accepts license extension submission for Invokana and Vokanamet
The decision is based on results from the landmark Phase III CREDENCE study
Read More
Author: Anna Smith
Multiple antibiotic courses linked to pediatric treatment failure
Data showed that those who had been given at least two previous courses were 32% more likely to fail to respond to a subsequent course.
Read More
NICE recommends antiseptics over antibiotics for impetigo
Antiseptic such as hydrogen peroxide 1% cream is ‘just as effective’ as a topical antibiotic.
Read More
HSE reimburses Braftovi combo
Eligible patients in the Republic of Ireland can potentially benefit from the combination with immediate effect.
Read More
One in seven five-year-olds don’t have MMR jabs
The lack of immunisation leaves children at high risk of measles at a time when outbreaks of the disease are occurring across the country.
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
